rocuronium and Guillain-Barre-Syndrome

Sugammadex encapsulates and inactivates rocuronium and vecuronium. It is used to reverse neuromuscular blockade from these nondepolarizing agents. The safety of sugammadex in patients with neuromuscular disease has not been established. Guillain-Barre Syndrome (GBS) is a neuromuscular disease characterized by acute inflammatory polyneuropathy. Patients with GBS may exhibit autonomic dysfunction, chronic pain, abnormal reactions to neuromuscular blocking agents, and may require postoperative mechanical ventilation. We report the successful use of sugammadex to reverse rocuronium in a patient with chronic GBS, who presented for a hemicolectomy.

Topics: Androstanols; gamma-Cyclodextrins; Guillain-Barre Syndrome; Humans; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Rocuronium; Sugammadex; Treatment Outcome; Vecuronium Bromide